Showing results (11-20 of 213) with videos related to
Sort By:
Pageof 22
Cancers|December 10, 2021
Differential Kat3 Usage Orchestrates the Integration of Cellular Metabolism with DifferentiationXiaohui Hu, Masaya Ono, Nyam-Osor Chimge, et al.Current Molecular Pharmacology|May 27, 2015
Specific Direct Small Molecule p300/β-Catenin Antagonists Maintain Stem Cell PotencyYusuke Higuchi, Cu Nguyen, Shin-Ya Yasuda, et al.Current Molecular Pharmacology|March 7, 2019
Convergence of Canonical and Non-Canonical Wnt Signal: Differential Kat3 Coactivator UsageKeane K Y Lai, Cu Nguyen, Kyung-Soon Lee, et al.Plos One|May 10, 2017
Small molecule p300/catenin antagonist enhances hematopoietic recovery after radiationYi Zhao, Kaijin Wu, Cu Nguyen, et al.Cancers|July 21, 2019
The Mode of Stem Cell Division Is Dependent on the Differential Interaction of β-Catenin with the Kat3 Coactivators CBP or p300Agnes I Lukaszewicz, Cu Nguyen, Elizabeth Melendez, et al.Stem Cells Translational Medicine|December 1, 2012
Wnt signaling orchestration with a small molecule DYRK inhibitor provides long-term xeno-free human pluripotent cell expansionKouichi Hasegawa, Shin-ya Yasuda, Jia-Ling Teo, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 23, 2015
Successful percutaneous coronary intervention for complex bifurcated lesions with combination of "Reverse wire technique" and "Reverse bent wiring with the crusade catheter" novel wire manipulation techniqueTetsuya Nomura, Yusuke Higuchi, Taku KatoCancers|March 30, 2018
Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic CancerPhilipp Manegold, Keane K Y Lai, Yongfeng Wu, et al.Expert Opinion on Therapeutic Targets|October 11, 2021
Taking the road less traveled - the therapeutic potential of CBP/β-catenin antagonistsMichael KahnFuture Medicinal Chemistry|October 19, 2011
Symmetric division versus asymmetric division: a tale of two coactivatorsMichael KahnPageof 22